(CGNX) Cognex - Overview
Sector: Technology | Industry: Scientific & Technical Instruments | Exchange: NASDAQ (USA) | Market Cap: 10.999m USD | Total Return: 119.2% in 12m
Avg Turnover: 138M
EPS Trend: 46.9%
Qual. Beats: 3
Rev. Trend: 84.8%
Qual. Beats: 3
Warnings
P/E ratio 77.8
Tailwinds
Supp Ema20, Rs Leader, Pead, Tailwind, Pullback 52w, Confidence
Cognex Corporation (CGNX) specializes in machine vision technology used to automate manufacturing and distribution processes globally. The company develops and markets a range of software and hardware, including the VisionPro and In-Sight systems, which utilize rule-based and deep learning-enabled tools to locate, identify, and inspect discrete items. Its product portfolio also includes image-based barcode readers and cloud-based AI platforms tailored for the automotive, logistics, and consumer electronics sectors.
The machine vision industry operates within the broader industrial automation sector, where companies increasingly adopt Industry 4.0 standards to reduce human error and increase throughput. Cognex maintains a high-margin business model by focusing on proprietary software algorithms and patented vision tools that integrate directly into robotic guidance and assembly verification systems. For a more comprehensive look at these industry drivers, ValueRay provides additional data on sector valuations.
Headquartered in Natick, Massachusetts, the company serves a diverse client base ranging from semiconductor manufacturers to e-commerce fulfillment centers. By providing both fixed-mount and handheld barcode verifiers alongside essential hardware like industrial lenses and controllers, Cognex positions itself as a full-stack provider of visual data analysis for complex supply chains.
- Consumer electronics capital expenditure cycles dictate short-term revenue volatility
- Logistics automation demand shifts impact long-term warehouse technology adoption
- Automotive sector transition to electric vehicles drives machine vision integration
- Greater China manufacturing slowdown poses significant geographical revenue concentration risk
- Expansion of AI-enabled deep learning software improves high-margin recurring revenue mix
| Net Income: 142.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.61 > 1.0 |
| NWC/Revenue: 46.20% < 20% (prev 42.81%; Δ 3.40% < -1%) |
| CFO/TA 0.12 > 3% & CFO 250.1m > Net Income 142.5m |
| Net Debt (-222.7m) to EBITDA (226.4m): -0.98 < 3 |
| Current Ratio: 3.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (168.4m) vs 12m ago -1.18% < -2% |
| Gross Margin: 68.02% > 18% (prev 0.68%; Δ 6.73k% > 0.5%) |
| Asset Turnover: 53.16% > 50% (prev 47.59%; Δ 5.57% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.24 (Total Current Assets 673.1m - Total Current Liabilities 189.5m) / Total Assets 2.01b |
| B: 0.17 (Retained Earnings 344.4m / Total Assets 2.01b) |
| C: 0.10 (EBIT TTM 196.3m / Avg Total Assets 1.97b) |
| D: 0.54 (Book Value of Equity 284.0m / Total Liabilities 526.6m) |
| Altman-Z'' = 3.38 = A |
| DSRI: 1.02 (Receivables 190.9m/163.9m, Revenue 1.05b/919.8m) |
| GMI: 1.00 (GM 68.02% / 68.30%) |
| AQI: 0.96 (AQ_t 0.59 / AQ_t-1 0.62) |
| SGI: 1.14 (Revenue 1.05b / 919.8m) |
| TATA: -0.05 (NI 142.5m - CFO 250.1m) / TA 2.01b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of May 29, 2026, the stock is trading at USD 66.01 with a total of 1,941,684 shares traded.
Over the past week, the price has changed by +4.31%,
over one month by +23.00%,
over three months by +21.50% and
over the past year by +119.21%.
Cognex has received a consensus analysts rating of 4.24. Therefore, it is recommended to buy CGNX.
- StrongBuy: 11
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 75.8 | 14.8% |
P/E Trailing = 77.7529
P/E Forward = 33.8983
P/S = 10.5073
P/B = 7.2319
P/EG = 2.7121
Revenue TTM = 1.05b USD
EBIT TTM = 196.3m USD
EBITDA TTM = 226.4m USD
Long Term Debt = 61.7m USD (estimated: total debt 74.0m - short term 12.3m)
Short Term Debt = 12.3m USD (from shortTermDebt, last quarter)
Debt = 74.0m USD (from shortLongTermDebtTotal, last quarter) (leases 74.0m already included)
Net Debt = -222.7m USD (calculated: Debt 74.0m - CCE 296.8m)
Enterprise Value = 10.8b USD (11.0b + Debt 74.0m - CCE 296.8m)
Interest Coverage Ratio = unknown (Ebit TTM 196.3m / Interest Expense TTM 0.0)
EV/FCF = 44.69x (Enterprise Value 10.8b / FCF TTM 241.1m)
FCF Yield = 2.24% (FCF TTM 241.1m / Enterprise Value 10.8b)
FCF Margin = 23.03% (FCF TTM 241.1m / Revenue TTM 1.05b)
Net Margin = 13.62% (Net Income TTM 142.5m / Revenue TTM 1.05b)
Gross Margin = 68.02% ((Revenue TTM 1.05b - Cost of Revenue TTM 334.8m) / Revenue TTM)
Gross Margin QoQ = 71.13% (prev 65.75%)
Tobins Q-Ratio = 5.37 (Enterprise Value 10.8b / Total Assets 2.01b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 74.0m)
Taxrate = 16.28% (10.1m / 61.8m)
NOPAT = 164.4m (EBIT 196.3m * (1 - 16.28%))
Current Ratio = 3.55 (Total Current Assets 673.1m / Total Current Liabilities 189.5m)
Debt / Equity = 0.05 (Debt 74.0m / totalStockholderEquity, last quarter 1.48b)
Debt / EBITDA = -0.98 (Net Debt -222.7m / EBITDA 226.4m)
Debt / FCF = -0.92 (Net Debt -222.7m / FCF TTM 241.1m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.24% (Net Income 142.5m / Total Assets 2.01b)
RoE = 9.56% (Net Income TTM 142.5m / Total Stockholder Equity 1.49b)
RoCE = 12.64% (EBIT 196.3m / Capital Employed (Equity 1.49b + L.T.Debt 61.7m))
RoIC = 9.09% (NOPAT 164.4m / Invested Capital 1.81b)
WACC = 12.38% (E(11.0b)/V(11.1b) * Re(12.46%) + D(74.0m)/V(11.1b) * Rd(0.0%) * (1-Tc(0.16)))
Discount Rate = 12.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.44 | Cagr: -1.09%
[DCF] Terminal Value 66.09% ; FCFF base≈209.6m ; Y1≈240.3m ; Y5≈353.7m
[DCF] Fair Price = 19.96 (EV 3.10b - Net Debt -222.7m = Equity 3.32b / Shares 166.4m; r=12.38% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 46.94 | EPS CAGR: 10.49% | SUE: 4.0 | # QB: 3
Revenue Correlation: 84.80 | Revenue CAGR: 6.71% | SUE: 3.77 | # QB: 3
EPS current Quarter (2026-06-30): EPS=0.42 | Chg30d=+35.42% | Revisions=+79% | Analysts=18
EPS next Quarter (2026-09-30): EPS=0.36 | Chg30d=+4.48% | Revisions=+41% | Analysts=18
EPS current Year (2026-12-31): EPS=1.47 | Chg30d=+17.49% | Revisions=+81% | GrowthEPS=+44.2% | GrowthRev=+11.1%
EPS next Year (2027-12-31): EPS=1.75 | Chg30d=+14.02% | Revisions=+81% | GrowthEPS=+19.2% | GrowthRev=+8.6%
[Analyst] Revisions Ratio: +81%